Dr Fauci Wants to Covid Vax Toddlers and Babies … but Pfizer Admits that Clinical Trials Conducted to Determine Long-Term Myocarditis Risks in Children are Too Short By Chris Knight (Florida)

Covid king Dr Fauci now wants babies and toddlers vaccinated. Next, I suppose, it will be all mammals, then all animals, then fish, insects and plants! Should inanimate objects such as rocks be injected with spike proteins too? Can spike proteins be injected with spike proteins, and so on in regression right down to the scale of quarks? In the Fauci world of magical vaxxes, who knows?

And, to end on a non-satirical note,  “Pharmaceutical giant Pfizer admits in documents submitted to the Food and Drug Administration (FDA) that clinical trials conducted to determine long-term myocarditis risks in children are too short. This information, which has not been made public by the company or the FDA, appears on page 11 of an FDA advisory committee briefing last October, in which Pfizer admitted its sample size of clinical trial volunteers was too small to detect myocarditis risks in children 5 to 12 years old.” For some reason the good doctor did not discuss this in his frantic desire to vaccinate all of reality.

And, what SARS-CoV-2, who “vaccinates” it, against vaccines? Oh, it just mutates, due to evolutionary pressure produced by the “leaky” vaccines.

 

https://thehill.com/policy/healthcare/582380-fauci-says-babies-and-toddlers-could-be-eligible-for-covid-19-vaccine-by

 


“Fauci says babies and toddlers could be eligible for COVID-19 vaccine by early 2022

 

 

Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci said Thursday that though he "can't guarantee it," babies and toddlers aged 6 months to 5 years could be eligible for COVID-19 vaccination by spring.

"Hopefully within a reasonably short period of time, likely the beginning of next year in 2022, in the first quarter of 2022, it will be available to them," Fauci told Insider in an interview, though he cautioned that he was speculating, adding, "you've got to do the clinical trial." 

Pfizer-BioNTech previously stated that results from their clinical trial in children in the age ranges of 2 to 5 years and 6 months to 2 years are expected as soon as the fourth quarter of this year.

According to a report by ABC Tampa in late October, Pfizer expects to apply this month for approval for its COVID-19 vaccine in children ages 6 months to 5 years, the last age range in the U.S. not yet being vaccinated.

"The Food and Drug Administration and CDC won't approve the vaccine until there's some data showing safety and efficacy," Philip Landrigan, a pediatrician and immunologist at Boston College, told CNN Health earlier this month.

"There's every reason to think that it will be safe, and it will be efficacious," Landrigan added. "But the agencies need to be cautious, justifiably so, and so they're not going to give the approval until they have the data."

According to CNN, Pfizer is the furthest along in trials for those aged 6 months to 5 years, but Moderna is also conducting studies in very young children.

"We don't have enough data now to present it for a regulatory approach, but right now, the data are being collected and analyzed," Fauci said when speaking to CNN earlier this month. "So we will be able to answer the question, I believe, within a reasonable period of time regarding the safety and the immunogenicity among those lower than 5 years old."

 

According to CNN, Johnson & Johnson is currently in the first phase three study in adolescents ages 12 to 17 years old and expect results in the coming months. 

 

The White House announced Wednesday that 10 percent of children ages 5 to 11 have received their first coronavirus shot, following the approval of the Pfizer pediatric dose.”

 

https://www.naturalnews.com/2021-11-17-pfizer-admits-more-studies-needed-covid-vaccine.html

“Pharmaceutical giant Pfizer admits in documents submitted to the Food and Drug Administration (FDA) that clinical trials conducted to determine long-term myocarditis risks in children are too short.

This information, which has not been made public by the company or the FDA, appears on page 11 of an FDA advisory committee briefing last October, in which Pfizer admitted its sample size of clinical trial volunteers was too small to detect myocarditis risks in children 5 to 12 years old.

The statement was buried in the briefing documents for Pfizer’s vaccine for kids under 12 years old. It reads: “The number of participants in the current clinical development program is too small to detect any potential risks of myocarditis associated with vaccination. Long-term safety of COVID-19 vaccine in participants 5 to <12 years of age will be studied in 5 post-authorization safety studies, including a 5-year follow-up study to evaluate long-term sequelae of post-vaccination myocarditis or pericarditis.”

In its overall risk-benefit conclusions, Pfizer stated that the number of participants in their current clinical development program is too small to detect any potential risks of myocarditis that is associated with vaccinations.

Despite this, the FDA still decided to issue emergency use authorization (EUA) for the Pfizer COVID-19 vaccine to be administered to children between the ages of five and eleven.

Meanwhile, the FDA delayed a similar EUA for Moderna, saying that they need to conduct a more thorough examination into the risk of myocarditis as the company’s vaccine formulation contains tromethamine – a drug that is used to treat metabolic acidosis, which usually occurs after heart bypass surgeries or cardiac arrests.

Parents question COVID vaccines for kids

Many American parents don’t plan on getting their kids vaccinated right away. The Centers for Disease Control and Prevention already extended Pfizer’s COVID vaccine eligibility to kids ages five to eleven, with other vaccines not far behind.

However, only about a third of parents with children in this age group plan on vaccinating their kids right away.

Their hesitation is understandable. Dr. Lee Savio Beers, president of the American Academy of Pediatrics said: “As parents, it’s our job to understand the health decisions that we’re making for our kids. There’s quite a bit of [Covid vaccine] information out there – much of it misinformation – which can be a little hard to filter through.”

COVID impacts children less than adults, and when they do get infected, they experience only very mild symptoms or none at all. Many parents also expressed their concern about the speed at which the vaccines were developed and the processes that were used to monitor their progress.

Kids will generally experience adverse effects from COVID vaccines similar to teens and adults, but with less severity, according to the FDA. This means that children may experience pain at the injection site, fatigue or headaches after their second dose, but they are less likely to get knocked out from the side effects.

Pfizer’s vaccines have a lower dosage for young children, with as little as 10 micrograms for kids ages five to 11 as opposed to the 30 micrograms for adults. The company found that at this dose, they get high levels of antivirus protection and low levels of side effects in younger children.

Still, parents should be concerned about the long-term side effects of COVID vaccines on their kids. While a report from the FDA found zero deaths or significant adverse events in Pfizer’s early vaccine trials for kids, the fact that the company admitted it needs more time to study the vaccine’s effects in kids is concerning.”

One thing that has puzzled me is why there should be any adverse effects from any vaccine, beyond the physically trivial, like pain at the injection site. Why phenomena such as fatigue and heat aches, let alone heart issues? Why should any of this happen at all?

 

 

Comments

No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Guest
Saturday, 27 November 2021
If you'd like to register, please fill in the username, password and name fields.

By accepting you will be accessing a service provided by a third-party external to https://blog.alor.org/